David P. King - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2008	1
2011	1
2012	1
2015	1
2022	0

Page 1

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.

Waring JF, Tang Q, Robieson WZ, King DP, Das U, Dubow J, Dutta S, Marek GJ, Gault LM. Waring JF, et al. Among authors: king dp. J Alzheimers Dis. 2015;47(1):137-48. doi: 10.3233/JAD-142589. J Alzheimers Dis. 2015. PMID: 26402762 Free PMC article. Clinical Trial.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW. King DP, et al. Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232. Epub 2011 Nov 2. Neuropsychopharmacology. 2012. PMID: 22048466 Free PMC article. Clinical Trial.

PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia.

Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, Fan YT, Paciga SA, Conti M, Menniti FS. Fatemi SH, et al. Among authors: king dp. Schizophr Res. 2008 Apr;101(1-3):36-49. doi: 10.1016/j.schres.2008.01.029. Epub 2008 Apr 3. Schizophr Res. 2008. PMID: 18394866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results